Photo: Alex Luna / Pexels
GMP Decoded: What the IPO Grey Market Premium Really Tells You
Before almost every buzzy IPO in India, one number races around WhatsApp groups, Telegram channels and trading forums faster than the prospectus ever will: the Grey Market Premium, or GMP. A new listing is "commanding a GMP of ₹150", the chatter says, and suddenly retail investors are rushing to apply. But the GMP is one of the most misunderstood figures in the market — and treating it as a promise of profit is a fast way to get burned.
This is a plain-English guide to what the Grey Market Premium actually is, the strange vocabulary that surrounds it (kostak, subject-to-sauda), why it so often misleads, and how a sensible investor should — and shouldn't — use it.
What the Grey Market Premium actually is
When a company launches an IPO, its shares aren't yet listed on the NSE or BSE, so there's no official price you can trade at until listing day. Into that gap steps an unofficial, off-the-books market — the grey market — where dealers and investors buy and sell IPO shares (and IPO applications) before they're listed.
The GMP is simply the extra amount, over and above the IPO issue price, that buyers in this grey market are willing to pay. If an IPO is priced at ₹500 and the GMP is ₹120, it implies the grey market expects the share to list around ₹620.
The crucial word is expects. GMP is not a quote from any exchange, not a SEBI figure, and not based on any audited data. It's a sentiment reading produced by a small, opaque circle of operators, settled in cash, with no contracts, no clearing house and no regulator standing behind it.
How the grey market runs — kostak and subject-to-sauda
The grey market doesn't just trade shares; it trades the applications themselves. Two pieces of jargon dominate this world, and serious IPO-watchers should know both:
- Kostak rate: A fixed price someone pays you to buy your entire IPO application, whether or not you get an allotment. If the kostak is ₹800, you pocket ₹800 the moment you sell your application, regardless of the lottery outcome.
- Subject-to-sauda (STS): A conditional deal that only triggers if shares are allotted to your application. No allotment means no transaction and no payout — but the per-share rate is usually higher to compensate for that risk.
These deals exist because IPO allotment in oversubscribed issues is a lottery, and some players would rather lock in a smaller, certain sum than gamble on getting shares. Operators act as middlemen, matching sellers of applications with buyers betting on a strong listing. None of it is recorded anywhere official.
Why the GMP so often misleads
Here's the uncomfortable truth: the GMP can be wrong, manipulated, or both. A few reasons it should never be taken at face value:
- It's set by very few hands. Because volumes are thin and concentrated, a handful of dealers can nudge the GMP up to manufacture hype around an issue they're invested in — or talk it down.
- It's hyper-volatile. GMP can swing wildly between the day an IPO opens and listing morning, reacting to subscription numbers, market mood, or pure rumour. The number you saw on day one is often not the one that matters.
- It reflects froth, not fundamentals. GMP measures short-term demand for listing-day flipping, not whether the business is worth owning. A loss-making company in a hot sector can show a fat premium; a solid, fairly-priced firm can show almost none.
- There's survivorship bias in the chatter. People loudly share the IPOs where a high GMP "called it right" and quietly forget the many where the stock listed flat or below issue price despite a strong premium.
The market has seen plenty of high-GMP IPOs disappoint on listing, and quietly-priced issues outperform. The premium is a mood ring, not a crystal ball.
What SEBI and the exchanges say
India's regulator does not endorse, monitor or publish GMP, and the stock exchanges have repeatedly cautioned investors not to rely on it. The grey market operates entirely outside the regulated framework, which means there is no recourse if a counterparty defaults on a cash deal.
To curb listing-day frenzy, SEBI and the exchanges already run a transparent, official mechanism: a special pre-open session on listing day where genuine buy and sell orders discover the opening price. That discovered price — not the grey market's whisper number — is the one that actually fills your demat account. Regulators would much rather you watch that than a figure cooked up in an unregulated bazaar.
How a sensible investor should use GMP
GMP isn't useless — it's just dangerous when misread. Treat it the way you'd treat crowd noise at a match: informative about mood, useless as a scoreboard. A practical approach:
- Use it only as a rough sentiment gauge. A consistently strong GMP across the bidding period suggests healthy demand, which can mean a positive listing. A collapsing GMP is a warning the hype is fading.
- Cross-check with subscription data. The official QIB, NII and retail subscription figures published by the exchanges are real, regulated numbers. Heavy institutional demand is a far more reliable signal than any grey-market whisper.
- Anchor on valuation, not premium. Read the issue's price-to-earnings against listed peers. If the IPO is expensive on fundamentals, a high GMP only means you're buying overpriced froth from someone else.
- Never chase the flip. Applying to an IPO purely because the GMP looks juicy is speculation, not investing. If you wouldn't want to own the company for years, a temporary premium is a poor reason to bid.
The bottom line
The Grey Market Premium survives because it scratches a real itch — investors desperately want to know what an IPO will do before it lists, and no official number offers that. But GMP fills that void with an unregulated, easily-gamed guess that frequently gets it wrong.
Know the lingo, understand the mechanics, and read GMP as one noisy input among many — alongside subscription figures, financials and valuation. The investors who consistently do well in IPOs aren't the ones tracking the premium to the rupee; they're the ones who decided the business was worth owning long before the grey market ever quoted a price.



